- 专利标题： NOVEL BISPECIFIC CD3/CD19 POLYPEPTIDE COMPLEXES
-
申请号： US16648792申请日： 2018-09-20
-
公开(公告)号： US20200283523A1公开(公告)日： 2020-09-10
- 发明人: Jieying LIU , Jianqing XU , Zhuozhi WANG , Qin MEI , Jing LI
- 申请人： WUXI BIOLOGICS IRELAND LIMITED
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3fb8bb3e
- 国际申请： PCT/CN2018/106776 WO 20180920
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; C12N15/63 ; A61P35/00 ; G01N33/68
摘要：
A bispecific anti-CD3×CD19 polypeptide complex that contains a first antigen-binding moiety of the polypeptide complex and a second antigen-binding moiety, methods of producing the bispecific anti-CD3×CD19 polypeptide complex, methods of treating disease or disorder using the bispecific anti-CD3×CD19 polypeptide complex, polynucleotides encoding the bispecific anti-CD3×CD19 polypeptide complex, vectors and host cells containing said polynucleotides, and compositions and pharmaceutical compositions comprising the bispecific anti-CD3×CD19 polypeptide complex are provided.
公开/授权文献
- US11365254B2 Bispecific CD3/CD19 polypeptide complexes 公开/授权日：2022-06-21
信息查询
